By Graeme J. Hankey, MBBS, MD, FRCP, FRCP(Edin), FRACP, 525 pp, with illus, $140, ISBN 13 978-0-521-82719-5, New York, NY, Cambridge University Press, 2006.
The ever-growing alphabet of clinical trials in stroke has reached a point where the naming of trials has become almost a parody of itself. Every new trial needs to have a catchy acronym: ACCORD, ACCOST, ADONIS, ALIAS, APLAUD, ARTIST, and ARUBA; and that's just a few of the A’s. More than anything, however, the growing number of large-scale trials in stroke that are planned, funded, executed, and published each year reflects the continued worldwide appreciation that evidence-based medicine is the only paradigm out of which unifying practice guidelines can be drawn.
Schwartz NE. Stroke Treatment and Prevention: An Evidence-based Approach. Arch Neurol. 2007;64(3):455. doi:https://doi.org/10.1001/archneur.64.3.455
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: